Carret Asset Management’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,983
| Closed | -$34.3K | – | 275 |
|
|
2024
Q4 | $34.3K | Buy |
1,983
+565
| +40% | +$9.78K | ﹤0.01% | 280 |
|
|
2024
Q3 | $38.6K | Buy |
1,418
+668
| +89% | +$18.2K | ﹤0.01% | 282 |
|
|
2024
Q2 | $30.5K | Buy |
750
+275
| +58% | +$11.2K | ﹤0.01% | 270 |
|
|
2024
Q1 | $31.6K | Buy |
475
+175
| +58% | +$11.7K | ﹤0.01% | 273 |
|
|
2023
Q4 | $34K | Buy |
+300
| New | +$34K | ﹤0.01% | 270 |
|
|
2023
Q3 | – | Sell |
-50
| Closed | -$18.3K | – | 275 |
|
|
2023
Q2 | $18.3K | Buy |
50
+27
| +117% | +$9.88K | ﹤0.01% | 266 |
|
|
2023
Q1 | $16K | Buy |
23
+3
| +15% | +$2.09K | ﹤0.01% | 265 |
|
|
2022
Q4 | $18K | Buy |
20
+3
| +18% | +$2.7K | ﹤0.01% | 272 |
|
|
2022
Q3 | $18K | Hold |
17
| – | – | ﹤0.01% | 268 |
|
|
2022
Q2 | $14K | Hold |
17
| – | – | ﹤0.01% | 275 |
|
|
2022
Q1 | $26K | Hold |
17
| – | – | ﹤0.01% | 294 |
|
|
2021
Q4 | $30K | Sell |
17
-6
| -26% | -$10.6K | ﹤0.01% | 295 |
|
|
2021
Q3 | $77K | Hold |
23
| – | – | 0.01% | 292 |
|
|
2021
Q2 | $103K | Hold |
23
| – | – | 0.01% | 291 |
|
|
2021
Q1 | $113K | Sell |
23
-17
| -43% | -$83.5K | 0.01% | 277 |
|
|
2020
Q4 | $74K | Buy |
+40
| New | +$74K | 0.01% | 269 |
|